Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.
Menter
M A
MA
Division of Dermatology, Baylor Psoriasis Center, Baylor University Medical Center, Dallas, TX, USA.
See
J A
JA
Amend
W J
WJ
Ellis
C N
CN
Krueger
G G
GG
Lebwohl
M
M
Morison
W L
WL
Prystowsky
J H
JH
Roenigk
H H
HH
Shupack
J L
JL
Silverman
A K
AK
Weinstein
G D
GD
Yocum
D E
DE
Zanolli
M D
MD
D000279:Administration, Cutaneous; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011701:PUVA Therapy; D010778:Photochemotherapy; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D012176:Retinoids; D016572:Cyclosporine; D008727:Methotrexate